Co-Diagnostics, Inc. Gain (Loss) on Sale of Derivatives
Co-Diagnostics, Inc. (CODX) reported Gain (Loss) on Sale of Derivatives of -$1.81 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-28.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnSaleOfDerivatives · last filed 2018-03-28
- Co-Diagnostics, Inc. gain (loss) on sale of derivatives for fiscal 2017 was -$1.81M.
- Co-Diagnostics, Inc. gain (loss) on sale of derivatives for fiscal 2016 was -$752.20K.
| Period end | Gain (Loss) on Sale of Derivatives 12 month |
|---|---|
| 2017-12-31 | -$1.81M 10-K · filed 2018-03-28 |
| 2016-12-31 | -$752.20K 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |